Fortrea Holdings Inc. (FTRE)
(Delayed Data from NSDQ)
$16.82 USD
-0.33 (-1.92%)
Updated Oct 31, 2024 04:00 PM ET
After-Market: $16.82 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth D Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
FTRE 16.82 -0.33(-1.92%)
Will FTRE be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for FTRE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FTRE
Blueprint Medicines (BPMC) Reports Q3 Loss, Tops Revenue Estimates
Do Options Traders Know Something About Fortrea Holdings (FTRE) Stock We Don't?
FTRE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fortrea Holdings Inc. (FTRE) Reports Q2 Loss, Lags Revenue Estimates
InflaRx N.V. (IFRX) Reports Q2 Loss, Lags Revenue Estimates
Caribou Biosciences, Inc. (CRBU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Other News for FTRE
Activist Corvex acquires stake in Fortrea Holdings, Bloomberg reports
Activist Corvex acquires stake in Fortrea Holdings, Bloomberg reports
12 Health Care Stocks Moving In Tuesday's After-Market Session
Fortrea gains after activist investor Corvex discloses stake
Fortrea price target lowered by $1 at Barclays, here's why